Glipizide 5 mg Tablets: Uses, Benefits, Dosage & Price in India

 GLIPIDIAB 5, containing Glipizide 5 mg, is an oral antidiabetic medicine from the sulfonylurea class. It is used as an adjunct to diet and exercise to improve blood-glucose control in adults with type 2 diabetes mellitus. Steris Healthcare offers pharmaceutical products with a focus on quality, consistency, and reliable supply. Glipizide requires appropriate medical supervision because sulfonylureas can cause hypoglycemia.

What is Glipizide (5mg) Tablets Used For?

Glipizide (5mg) Tablets are primarily used for managing type 2 diabetes when diet, exercise, and other appropriate measures alone are not sufficient to achieve the desired blood-glucose control. Glipizide works by encouraging the pancreas to release insulin, helping the body reduce elevated blood-glucose levels.

GLIPIDIAB 5 should be used according to the healthcare professional's prescription and as part of an overall diabetes-management plan that may include appropriate nutrition, physical activity, and regular blood-glucose monitoring. Glipizide is not intended for treating type 1 diabetes or diabetic ketoacidosis.

Why It's Important 

Maintaining appropriate blood-glucose levels is an important part of long-term type 2 diabetes management. Uncontrolled diabetes can increase the risk of complications affecting the cardiovascular system, kidneys, eyes, nerves, and other organs.

Glipizide 5 mg is particularly important to understand because its glucose-lowering action is associated with increased insulin secretion. The medicine can therefore be effective for suitable patients but can also cause blood glucose to fall too low, especially when meals are missed, caloric intake is inadequate, exercise is unusually strenuous, alcohol is consumed, or other glucose-lowering medicines are used.

For this reason, patients should not select or adjust GLIPIDIAB 5 independently. The appropriate dose should be determined according to individual glucose control, response to treatment, age, kidney or liver function, and other medicines.

Key Benefits of Glipizide (5mg) Tablets

What Are the Benefits 

The potential benefits of GLIPIDIAB 5 (Glipizide 5 mg) include:

• Helps lower elevated blood-glucose levels in appropriate adults with type 2 diabetes.
• Stimulates the pancreas to release insulin when functioning pancreatic beta cells are present.
• Can improve glycemic control when combined with an appropriate diet and exercise program.
• May help reduce post-meal increases in blood glucose because insulin secretion in response to meals is an important part of its action.
• Provides an established oral sulfonylurea treatment option when considered appropriate by a healthcare professional.

These benefits should be understood as treatment effects rather than a cure for diabetes. Individual response varies, and ongoing glucose monitoring remains important.

Mechanism of Action 

Glipizide belongs to the second-generation sulfonylurea class. Its primary glucose-lowering action is to stimulate insulin secretion from functioning pancreatic beta cells. At the cellular level, glipizide inhibits ATP-sensitive potassium channels in pancreatic beta cells. This causes membrane depolarization, which promotes calcium entry into the cells and subsequently triggers insulin release.

The increased insulin availability helps the body utilize glucose more effectively and contributes to lower blood-glucose levels. Because its action depends on functioning pancreatic beta cells, glipizide is not appropriate for treating type 1 diabetes or diabetic ketoacidosis.

Side Effects 

Like other medicines, Glipizide 5 mg can cause side effects, although not everyone experiences them.

The most clinically important adverse effect is hypoglycemia (low blood sugar). Symptoms may include sweating, shakiness, hunger, dizziness, weakness, headache, confusion, irritability, or difficulty concentrating. The risk can increase with excessive dosing, inadequate food intake, strenuous exercise, alcohol, or concurrent glucose-lowering medicines.

Other possible adverse effects can include gastrointestinal symptoms and allergic or skin reactions. If unusual or persistent symptoms occur, medical advice should be sought.

Serious Side Effects 

Severe hypoglycemia can become a medical emergency. Serious symptoms may include significant confusion, loss of consciousness, seizures, or other neurological impairment. Immediate medical attention is required if severe low blood sugar is suspected.

Glipizide can also require additional caution in people with kidney or liver impairment because reduced clearance may increase exposure and prolong hypoglycemia. Rare blood-related reactions can also occur; patients who develop unusual symptoms should contact their healthcare professional promptly.

Available Substitute 

The appropriate substitute for GLIPIDIAB 5 depends on the patient's blood-glucose levels, treatment history, other medicines, kidney and liver function, age, and risk of hypoglycemia.

Possible alternatives within diabetes treatment may include other sulfonylureas or different classes of glucose-lowering medicines. However, a substitute should not be selected solely on the basis of the same strength or price. A doctor or qualified healthcare professional should determine whether another medicine is appropriate.

Dosage Guidelines 

For immediate-release glipizide tablets, prescribing information states that the recommended starting dose is commonly 5 mg before breakfast, while some older adults or patients with liver disease may require a lower starting dose. Dose adjustments are based on blood-glucose response and should be made under medical supervision. Immediate-release glipizide is generally administered approximately 30 minutes before a meal.

Importantly, GLIPIDIAB 5 should not be dosed solely according to information found online. The exact regimen depends on the formulation and the individual patient's needs. Immediate-release and extended-release glipizide products have different dosing instructions; therefore, patients should follow the directions on their specific prescription and product label.

Regular blood-glucose and, when advised, HbA1c monitoring can help determine whether treatment is providing adequate control.

Precautions & Warnings 

Before using GLIPIDIAB 5, discuss your medical history and current medicines with your healthcare professional.

Important precautions include:

• Glipizide can cause hypoglycemia, which may sometimes be severe.
• Do not skip or significantly reduce meals while taking the medicine unless your healthcare professional gives specific instructions.
• Extra caution may be required in elderly, malnourished, debilitated, or medically vulnerable patients.
• Kidney or liver impairment may increase the risk or duration of hypoglycemia.
• Alcohol may increase the risk of low blood sugar.
• Tell your doctor about all antidiabetic medicines and other prescription or non-prescription products you use.
• Glipizide is not indicated for type 1 diabetes or diabetic ketoacidosis.
• Patients with G6PD deficiency may require consideration of alternative treatment because hemolytic anemia has been reported with sulfonylureas.

Patients should also understand the symptoms of low blood sugar and know how to respond according to their healthcare professional's instructions.

Conclusion

Glipizide (5mg) Tablets, marketed as GLIPIDIAB 5 by Steris Healthcare, are an oral sulfonylurea medicine used with diet and exercise to improve blood-glucose control in appropriate adults with type 2 diabetes. Its principal action is to stimulate insulin release from functioning pancreatic beta cells.

Because hypoglycemia can be a significant adverse effect, GLIPIDIAB 5 should be taken strictly according to a healthcare professional's prescription. Appropriate dosing, regular glucose monitoring, consistent meals, and awareness of warning symptoms are important parts of safe treatment. For purchasing or product-related information in India, customers should verify the exact strength, formulation, pack details, and prescription requirements with the authorized supplier or Steris Healthcare Pvt. Ltd.